Kathryn R. Gardner, MS
- 2Articles
- 11.2KReads1
- 2015Active
- 8Collaborators
- 19Citations2
About
Kathryn R. Gardner, MS, has contributed to research on the application of pharmacogenetic testing in the treatment of mood and anxiety disorders, with a focus on major depressive disorder. Gardner's work includes studies on guiding psychiatric treatment and addressing antidepressant-related motor disturbances. Publications appeared in 2015 in Psychiatrist.com (The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders). Frequent collaborators include Francis X. Brennan, Herbert W. Harris, Jay Lombard, Karen H. Rhea, and Maurizio Fava.
Publications
A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders
April 16, 2015
The Role of Pharmacogenetic Testing in the Amelioration of Antidepressant-Related Motor Disturbances in 2 Young Adult Men With Major Depressive Disorder
January 8, 2015
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
